$ONTX Would love to open a discussion on these thoughts: "Market cap is around 156M$" "ON drug potential market is around 13.000M$" "More drugs are on trial phases" "Risk coming from poor finance and management, and trial ending seems far" Those are my pros and cons for this company, do you agree? Have you more insights on it? From my perspective (being at .90$ average) it is worth waiting for some of their drugs to see the lights
1 Like